Meet Adaeze Nwosu Iheme, M.D.
Adaeze Nwosu Iheme, M.D.
Department of General Oncology, Division of Cancer Medicine
About Dr. Adaeze Nwosu Iheme
Dr. Adaeze Iheme is a breast medical oncologist at MD Anderson Cancer Center, she completed her fellowship training in Hematology and Oncology at the University of Florida in Gainesville and her internal medicine residency training at Beth Israel Hospital in New Jersey. She is very passionate about caring for her patients with breast cancer and treats every patient like her family member. She is particularly interested in breast cancer genetics and educating the public on their risks of breast and other cancers. Dr Iheme is board certified in both oncology and hematology. She is a member of the American Society of Clinical Oncology, has co-authored peer reviewed publications and given oral and poster presentations at the national conferences.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor (Joint appointment), Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor (Joint Appointment), Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2013 | St. George's University School of Medicine, West Indies, GD, MD |
| 2008 | IMO State University, IMO, NG, MD |
Postgraduate Training
| 2016-2019 | Clinical Fellowship, Hematology/Oncology, University of Florida, Gainesville, Florida |
| 2013-2016 | Clinical Residency, Internal Medicine, Newark Beth Israel Medical Center, Newark, New Jersey |
Board Certifications
| 2019 | American Board of Internal Medicine-Hematology |
| 2016 | American Board of Internal Medicine |
Experience & Service
Other Appointments/Responsibilities
Consultant, Victoria Hematology-Oncology Associates, Victoria, TX, 2019 - Present
Honors & Awards
| Gold Stethoscope Award, WIMS Nigeria | |
| American College of Physician's Young Achiever's Award, American College of Physicians | |
| Top Resident Representative, Resident Cultural Forum | |
| RWJ Barnabas Health Chief Resident, Beth Israel Medical Center | |
| Travel Award, Florida Association of Clinical Oncology | |
| ASCO Educational Book Expert Panel, ASCO |
Selected Publications
Peer-Reviewed Articles
- Skelton WP, Dibenedetto SW, Pang SS, Pan K, Barish JL, Nwosu-Iheme A, Dang L. A Single-center Retrospective Analysis of the Effect of Radium-223 (Xofigo) on Pancytopenia in Patients with Metastatic Castration-resistant Prostate Cancer. Cureus 12(1):e6806, 2020. e-Pub 2020. PMID: 32140364.
- Nwosu-Iheme A, Ghanem S, Patel A, Zhuang Y, Seifert R, Murthy H. A Rare Presentation of Hemophagocytic Lymphohistiocytosis in a Patient with Untreated Chronic Lymphocytic Leukemia: A case report and review of the literature. Herbert Open Access Journals 6(2):1-5, 2018. PMID: None.
- Patel A, Ghanem S, Nwosu-Iheme A, Fletcher B. Idiopathic Pulmonary Vein Thrombosis – A presentation of two case reports and review of the current literature. Symbiosis online publishing 2:1-6, 2017. PMID: None.
- Vijaykumar, Baran D, Nwosu-Iheme A. Successful Use of Extracorporeal Membrane Oxygenation for Silicone Embolism Syndrome and Pulmonary Hemorrhage. Chest Journal, 2016. e-Pub 2016. PMID: None.
- Orsini J, Nwosu-Iheme A, Medavaram S, Cohen AJ. Pituitary Metastasis from Breast Cancer Presenting as SIADH. Journal Of Endocrinology & Metabolism 5(4):256-260, 2015. PMID: None.
- Shah S, Nwosu-Iheme A, Cohen AJ. Impact of Hydroxyurea on Sickle Cell Patients Managed in a Community Medical Center. Ash Publications 126(23):3411, 2015. PMID: None.
Editorials
- Nwosu-Iheme A, Unnikrishnan A. Selecting Patients for CDK4/6 inhibitors in Metastatic Breast Cancer. ASCO Daily Post. PMID: None.
Abstracts
- Valero V, Mouabbi J, Alonzo H, Nwosu-Iheme A, Murthy R, Huang X, Qiao W, Patel M, Pohlmann PR, Rauch G, Checka C, Hunt K, Tripathy D, Meric-Bernstam F, Symmans F. 132P Neoadjuvant zanidatamab for stage I node-negative HER2- positive breast cancer (BC). ESMO Open 8(1), 2023. PMID: None.
- Patel A, Forat Lufti AA, Adaeze N, Markham MJ. An Interactive Multimodality Curriculum Teaching Medicine Residents about Oncologic Documentation and Billing. The Journal of Teaching and Learning Resources 8265, 2018. PMID: None.
- Adaeze N, Cohen AJ. 3411 Impact of Hydroxyurea on Sickle Cell Patients in a Community Hospital. American Society of Hematology 126(23), 2015. PMID: None.
Selected Presentations & Talks
Local Presentations
- 2023. Patient Education and Empowerment Webinar on Understanding HER2+ and Early-Stage Breast Cancer. Invited. National African American Breast Cancer Survivorship Organization. Houston, TX, US.
- 2023. Breast Cancer Screening and Current Approaches to Treatment. Invited. Houston, Texas, US.
- 2023. Surviving Breast Cancer. Invited. Houston, Texas, US.
- 2022. Question and Answer Session on Breast Cancer. Invited. Houston, Texas, US.
- 2022. Power of Breast Cancer Survivorship. Invited. Houston, Texas, US.
Regional Presentations
- 2023. The Efficacy and Safety of Tinengotinib in Patients with Advanced or Metastatic HR+/HER2-breast Cancer or TNBC. Invited. San Antonio, TX, US.
- 2022. Black Women Speak Symposium on dismantling barriers in breast cancer, increasing participation of minorities in clinical trials. Invited. San Antonio, TX, US.
Patient Reviews
CV information above last modified January 21, 2025